BETA: Please send your feedback!
Continental Resources
CLR:NYS
Oil & Gas Production
$10.77bn
LARGE cap
$28.76
(-1.32%)
-0.36%
since start of 2019
11.49
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2003
Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test; Horizon Carrier Screening; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis; Anora Products of Conception; and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| J. Warren Henry, MBA | Vice President-Investor Relations & Research | Male |
| John D. Hart, CPA | Chief Financial Officer, Treasurer & Senior VP | Male |
| Jack H. Stark | President | Male |
| Harold G. Hamm | Chairman & Chief Executive Officer | Male |
| Tony C. Maranto | Chief Operating Officer | Male |
| Eric Spencer Eissenstat | Secretary, Chief Risk Officer & General Counsel | Male |
| Blu Hulsey | Vice President-Government & Regulatory Affairs | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 2
Natera - Competitors and Related Companies
How Natera stacks up to its peers in the Biotechnology industry or with competing business segments.
Natera
NTRA:NAS
Biotechnology
$2.27bn
SMALL cap
$32.32
(1.33%)
1.54%
since start of 2019
-16.00
Loading…